Companies in GWDN Index Rise and Fall on Q1 Earnings Reports in May | GenomeWeb

NEW YORK (GenomeWeb) – The GenomeWeb Index rose nearly 4 percent in May as companies' fortunes largely depended on the strengths or weaknesses of their first quarter earnings reports.

The Index significantly outperformed the Dow Jones Industrial Average, which gained less than a tenth of a percent during the month, but was roughly in line with the Nasdaq, which gained nearly 4 percent, and the Nasdaq Biotechnology Index, which finished the month a little more than 4 percent higher.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.